Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does METHYLPREDNISOLONE Cause Colitis ischaemic? 15 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Colitis ischaemic have been filed in association with METHYLPREDNISOLONE (Medroloan II SUIK). This represents 0.0% of all adverse event reports for METHYLPREDNISOLONE.

15
Reports of Colitis ischaemic with METHYLPREDNISOLONE
0.0%
of all METHYLPREDNISOLONE reports
4
Deaths
9
Hospitalizations

How Dangerous Is Colitis ischaemic From METHYLPREDNISOLONE?

Of the 15 reports, 4 (26.7%) resulted in death, 9 (60.0%) required hospitalization, and 1 (6.7%) were considered life-threatening.

Is Colitis ischaemic Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for METHYLPREDNISOLONE. However, 15 reports have been filed with the FAERS database.

What Other Side Effects Does METHYLPREDNISOLONE Cause?

Off label use (10,364) Drug ineffective (9,959) Product use in unapproved indication (4,115) Condition aggravated (3,784) Headache (3,419) Fatigue (3,250) Pyrexia (3,226) Pain (3,165) Nausea (3,105) Pneumonia (3,006)

What Other Drugs Cause Colitis ischaemic?

QUETIAPINE (209) CLOZAPINE (139) ASPIRIN (137) OLANZAPINE (126) LENALIDOMIDE (111) ADALIMUMAB (97) CARBOPLATIN (91) RIVAROXABAN (90) DABIGATRAN ETEXILATE (85) SUMATRIPTAN (78)

Which METHYLPREDNISOLONE Alternatives Have Lower Colitis ischaemic Risk?

METHYLPREDNISOLONE vs METHYLPREDNISOLONE ACEPONATE METHYLPREDNISOLONE vs METHYLPREDNISOLONE HEMISUCCINATE METHYLPREDNISOLONE vs METILDIGOXIN METHYLPREDNISOLONE vs METOCLOPRAMIDE METHYLPREDNISOLONE vs METOLAZONE

Related Pages

METHYLPREDNISOLONE Full Profile All Colitis ischaemic Reports All Drugs Causing Colitis ischaemic METHYLPREDNISOLONE Demographics